Based on the analysis of Check Cap's profitability, liquidity, and operating efficiency, Check Cap is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. At this time, Check Cap's Common Stock is quite stable compared to the past year. Property Plant Equipment is expected to rise to about 3.4 M this year, although the value of Other Liabilities will most likely fall to about 80.4 K. Key indicators impacting Check Cap's financial strength include:
Investors should never underestimate Check Cap's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Check Cap's cash flow, debt, and profitability to make informed and accurate decisions about investing in Check Cap.
Net Income
(16.6 Million)
Check
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Investments
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Short Term Investments
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Common Stock
Property Plant Equipment
Net Tangible Assets
Net Receivables
Non Currrent Assets Other
Inventory
Capital Surpluse
Net Invested Capital
Net Working Capital
Capital Stock
Short Long Term Debt Total
Capital Lease Obligations
Short Term Debt
Depreciation And Amortization
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Gross Profit
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Interest Income
Selling And Marketing Expenses
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Check Cap Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Check Cap's financial statements are interrelated, with each one affecting the others. For example, an increase in Check Cap's assets may result in an increase in income on the income statement.
Check Cap competes with Fonar, Burning Rock, Sera Prognostics, DarioHealth Corp, and Biodesix. Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. The company was incorporated in 2004 and is based in Isfiya, Israel. Check-Cap operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 81 people.
Comparative valuation techniques use various fundamental indicators to help in determining Check Cap's current stock value. Our valuation model uses many indicators to compare Check Cap value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Check Cap competition to find correlations between indicators driving Check Cap's intrinsic value. More Info.
Check Cap is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Check Cap's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Check Cap by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Check Cap Systematic Risk
Check Cap's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Check Cap volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Check Cap correlated with the market. If Beta is less than 0 Check Cap generally moves in the opposite direction as compared to the market. If Check Cap Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Check Cap is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Check Cap is generally in the same direction as the market. If Beta > 1 Check Cap moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Check Cap Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Check Cap's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Check Cap growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Check Cap help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Check Cap. We use our internally-developed statistical techniques to arrive at the intrinsic value of Check Cap based on widely used predictive technical indicators. In general, we focus on analyzing Check Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Check Cap's daily price indicators and compare them against related drivers.
When determining whether Check Cap is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Check Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Check Cap Stock. Highlighted below are key reports to facilitate an investment decision about Check Cap Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Check Cap. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Check Stock please use our How to buy in Check Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Check Cap. If investors know Check will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Check Cap listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.14)
Return On Assets
(0.33)
Return On Equity
(0.53)
The market value of Check Cap is measured differently than its book value, which is the value of Check that is recorded on the company's balance sheet. Investors also form their own opinion of Check Cap's value that differs from its market value or its book value, called intrinsic value, which is Check Cap's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Check Cap's market value can be influenced by many factors that don't directly affect Check Cap's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Check Cap's value and its price as these two are different measures arrived at by different means. Investors typically determine if Check Cap is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Check Cap's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.